AGER

AGER Protein

Score: 0.297 Price: $0.30 Undruggable Druggability Status: active Wiki: AGER Gene
HYPOTHESES
1
PAPERS
7
KG EDGES
0
DEBATES
0

3D Protein Structure

🧬 AGER — PDB 3CJJ Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

Druggability & Clinical Context

Druggability
Undruggable
Score: 0.23
Clinical Stage
Preclinical
Target Class
Protein
Safety
0.50
Druggability Analysis
Drug Development0.00
Structural Tractability0.30
Target Class0.50
Safety Profile0.50
Key Metrics
PDB Structures:
0
Known Drugs:
10
Approved:
0
In Clinical Trials:
0
Drug Pipeline (10 compounds)
10 Preclinical
Mechanism: Prioritized from 1 SciDEX hypotheses, including: Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuroinflammatory Cascade
Drug Pipeline (10 compounds)
10 Preclinical
Known Drugs:
CHEMBL2179074 (preclinical)
CHEMBL2205553 (preclinical)
CHEMBL2205552 (preclinical)
CHEMBL2205550 (preclinical)
CHEMBL2205549 (preclinical)
CHEMBL2205572 (preclinical)
CHEMBL2205569 (preclinical)
CHEMBL2205568 (preclinical)
Structural Data:
PDB —AlphaFold ✓Cryo-EM —
UniProt: Q15109

🧬 3D Protein Structure

🧬 AGER — PDB 3CJJ Click to expand interactive 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll

3D Protein Structure (AlphaFold)

Open full viewer

AlphaFold predicted structure available for Q15109

View AlphaFold Structure

Linked Hypotheses (1)

Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuroinflammatory Cascade0.613

Linked Experiments (0)

No linked experiments

Scoring Dimensions

Portfolio 0.00 (25%) Druggability 0.23 (20%) Evidence 0.59 (20%) Safety 0.50 (15%) Competitive 0.60 (10%) Connectivity 0.00 (10%) 0.297 composite

Knowledge Graph (20)

associated with (6)

AGERMICROVASCULAR_COMPLICATIONSHSPA1BAGERAGERHSPA1AHSPA1AAGERAGERHSPA1B
▸ Show 1 more
AGERneurodegeneration

binds to (2)

AGERHSPA1AAGERHSPA1B

co discussed (6)

TDCAGERTLR4AGERDDCAGERGPR109AAGERCHRNA7AGER
▸ Show 1 more
AGERCSGA

debate co mention (1)

AGERCHRNA7

implicated in (2)

AGERtype 2 diabetesAGERmetabolic diseases

interacts with (2)

AGERHSPA1AAGERHSPA1B

references (1)

TIA1L ProteinAGER

Debate History (0)

No debates yet